Some individuals may experience shingles or chickenpox-like rashes within 42 days after receiving zoster vaccine. Transmission of VZV virus from vaccinated individuals to other individuals occurs rarely.
GENERIC AVAILABLE: No
PREPARATIONS: Powder for Injection: 0.65 ml
STORAGE: Powder should be stored frozen at 15 C (5 F) or colder until ready to use. Diluent should be stored at room temperature (20 C - 25 C [68 F - 77 F]) or refrigerated at (2 C - 8 C [36 F - 46 F]).
DOSING: Zoster vaccine is injected subcutaneously (under the skin) in the upper arm. The recommended dose is 0.65 ml.
DRUG INTERACTIONS: In clinical studies, concomitant use of zoster vaccine and Pneumovax reduced the activity of zoster vaccine.
PREGNANCY: Zoster vaccine is not used for preventing shingles in women of child bearing age and should not be administered to pregnant women.
NURSING MOTHERS: Zoster vaccine is not used for preventing shingles in nursing mothers.
Medically reviewed by Eni Williams, PharmD
Reference: FDA Prescribing Information for Zostavax
Quick GuideShingles Pictures Slideshow: A Collection of Photos on Shingles
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.